PartnershipUpdated on 25 January 2026
BIOTECH: Finding funding to develop Novel Neuropsychiatric Drugs via Computational Multi-Target Drug Design
About
We would like to find potential strategic partnership for funding a co-development of Novel Neuropsychiatric Drugs via Computational Multi-Target Drug Design, aiming for treatment-resistant depression patients.
Similar opportunities
Partnership
BIOTECH: Finding a strategic partner to develop novel psychitric drugs
Dorit Cohen
Founder & CEO at ReSynapse Therapeutics
Nes Ziona, Israel
Partnership
Do Youn Chun
Chief Technical Officer at AT-31 BIO Inc.
Daegu, South Korea
Partnership
Microrobotic Platform for Targeted CNS Drug Delivery
Arthur Piovezan
Business Development Lead at Robeauté
Paris, France